SANGAMO THERAP.INC.DL-,01 revenue breakdown overview

SANGAMO THERAP.INC.DL-,01 revenue for the last year amounted to 159.67 M EUR, the most of which — 159.67 M EUR — came from its highest performing source at the moment, Zinc Finger Protein, the year earlier bringing 103.99 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought SANGAMO THERAP.INC.DL-,01 159.67 M EUR, and the year before that — 103.99 M EUR.